Novosanis is a Belgian medical device start-up company that has developed a device platform that allows the collection of different pre-defined urine volumes for a range of medical applications (e.g. chlamydia, gonorrhoea and HPV, which can cause cervical cancer, as well as cancer biomarkers). From their first day of business the start-up has been working together with other partners. Their first commercial product (Colli-Pee) was developed with the help of the University of Antwerp and Voxdale (a design & engineering company). It is unique in that it provides a user-friendly, non-invasive sampling method intended for home-use by patients.
Open innovation for SME's
